Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000873423 | SCV001015415 | benign | KBG syndrome | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001638009 | SCV001848075 | benign | not provided | 2019-01-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001638009 | SCV001961632 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | ANKRD11: BP4, BP7, BS1 |
Genome- |
RCV000873423 | SCV002524179 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372477 | SCV002624923 | likely benign | Inborn genetic diseases | 2017-06-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000873423 | SCV004564673 | benign | KBG syndrome | 2023-10-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003938327 | SCV004751626 | likely benign | ANKRD11-related condition | 2019-03-07 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |